Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Simcere Pharmaceutical Group's (Dexborneol + Edaravone)?
(Dexborneol + Edaravone) is a small molecule commercialized by Simcere Pharmaceutical Group, with a leading Phase I program in Acute...